NCT06650488View on ClinicalTrials.gov

Clopidogrel Vs. Aspirin in Patients with S. Aureus Bacteremia

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 7, 2025

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
Staphylococcus Aureus EndocarditisStaphylococcus Aureus SepticemiaStaphylococcus Aureus Bloodstream Infection
Interventions
DRUG

Clopidogrel

Patients will change from aspirin to clopidogrel (without loading dose)

DRUG

Aspirin

Patients will continue their existing aspirin.

Trial Locations (1)

H4A3S1

McGill University Health Centre (Royal Victoria Hospital and Montreal General Hospital), Montreal

All Listed Sponsors
lead

Todd C. Lee MD MPH FIDSA

OTHER